Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Unresectable Metastatic Colo-rectal Cancer”

296 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 296 results

Testing effectiveness (Phase 2)Study completedNCT00778102
What this trial is testing

Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 80
Testing effectiveness (Phase 2)Study completedNCT03647839
What this trial is testing

Modulation Of The Tumour Microenvironment Using Either Vascular Disrupting Agents or STAT3 Inhibition in Order to Synergise With PD1 Inhibition in Microsatellite Stable, Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Australasian Gastro-Intestinal Trials Group 90
Testing effectiveness (Phase 2)Study completedNCT03981614
What this trial is testing

Binimetinib and Palbociclib or TAS-102 in Treating Patients With KRAS and NRAS Mutant Metastatic or Unresectable Colorectal Cancer

Who this might be right for
Metastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8+3 more
Academic and Community Cancer Research United 102
Very early researchLooking for participantsNCT07050394
What this trial is testing

A Dose-Expansion Trial of Intravenous HNF4α srRNA for Unresectable or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticColorectal Cancer RecurrentColorectal Cancer Stage IV
Shanghai Changzheng Hospital 20
Not applicableLooking for participantsNCT01365169
What this trial is testing

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Who this might be right for
Malignant Head and Neck NeoplasmMalignant NeoplasmMetastatic Malignant Neoplasm in the Neck+45 more
M.D. Anderson Cancer Center 590
Not applicableNot Yet RecruitingNCT06079242
What this trial is testing

Observational Study for SIR-Spheres Therapy for the Treatment of Unresectable Metastatic Liver Tumors From Primary Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
GrandPharma (China) Co., Ltd. 200
Early research (Phase 1)Looking for participantsNCT05985954
What this trial is testing

Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy

Who this might be right for
Metastatic Colorectal Cancer
M.D. Anderson Cancer Center 27
Large-scale testing (Phase 3)Study completedNCT00265824
What this trial is testing

Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 700
Testing effectiveness (Phase 2)Looking for participantsNCT06682793
What this trial is testing

Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNon-Small Cell Lung+14 more
A2 Biotherapeutics Inc. 240
Testing effectiveness (Phase 2)Study completedNCT01328171
What this trial is testing

FOLFOXIRI With or Without Panitumumab in Metastatic Colorectal Cancer (VOLFI)

Who this might be right for
Metastatic Colorectal Cancer
AIO-Studien-gGmbH 93
Not applicableActive Not RecruitingNCT02394834
What this trial is testing

An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer

Who this might be right for
Colorectal Cancer
Takeda 757
Large-scale testing (Phase 3)Not Yet RecruitingNCT07509398
What this trial is testing

FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer

Who this might be right for
Unresectable Colorectal CancerColorectal Cancer (Locally Advanced or Metastatic)
Shanghai 10th People's Hospital 220
Testing effectiveness (Phase 2)UnknownNCT01322178
What this trial is testing

Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer Patients

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 90
Testing effectiveness (Phase 2)Study completedNCT00019760
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver

Who this might be right for
Recurrent Colon CancerLiver MetastasesStage IV Rectal Cancer+2 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Looking for participantsNCT06980532
What this trial is testing

Glumetinib Combined With Fruquintinib in the Treatment of MET Amplification or Protein Overexpression in Third-Line Unresectable Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Liu Huang 42
Not applicableStudy completedNCT04517643
What this trial is testing

TheraSphere® For Treatment of Metastases in Liver

Who this might be right for
Colorectal Cancer MetastaticColorectal Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 4
Large-scale testing (Phase 3)UnknownNCT00002793
What this trial is testing

Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Johann Wolfgang Goethe University Hospital 336
Testing effectiveness (Phase 2)UnknownNCT04160416
What this trial is testing

MXELOXIRI Combined With Molecular Targeted Drug in mCRC

Who this might be right for
Unresectable Metastatic Colorectal Cancer
First Affiliated Hospital of Zhejiang University 48
Not applicableStudy completedNCT03602885
What this trial is testing

EL CENTRO: Engaging Latinos in the Center of Cancer Treatment Options

Who this might be right for
Metastatic Pancreatic CancerUnresectable Pancreatic CancerMetastatic Colorectal Cancer
Dana-Farber Cancer Institute 10
Testing effectiveness (Phase 2)UnknownNCT04866108
What this trial is testing

A Phase II Study of Fruquintinib Combined With Capecitabine as First-line Treatment for Advanced Metastatic Colorectal Cancer Unsuitable for Intravenous Chemotherapy

Who this might be right for
Unresectable Metastatic Colorectal Cancer
Beijing Friendship Hospital 49
Load More Results